Barclays Adjusts Price Target on Welltower to $259 From $254, Keeps Equalweight Rating

Welltower (WELL), Ventas (VTR), and Omega Healthcare (OHI) are REITs benefiting from a demographic wave of aging baby boomers. Welltower reported Q2 2026 revenue of $3.54B, up 40.9% YoY, and raised FFO guidance. Ventas saw 9% YoY FFO growth and shifted focus to SHOP. Omega Healthcare improved AFFO and raised its dividend. All three companies are positioned to capitalize on increased demand for senior housing and skilled nursing facilities.

Morgan Stanley's Ronald Kamdem expects senior housing REITs to continue outperforming due to aging population and high demand. Welltower (WELL) and American Healthcare REIT (AHR) are rated overweight, with price targets of $251 and implied upside, respectively. Ventas (VTR) is rated equal weight. All three REITs show strong occupancy and acquisition growth potential, with Welltower's dividend yield at 1.44%.

Morgan Stanley maintained an Overweight rating on Welltower (WELL) and raised its price target to $251 from $215. Welltower's stock is currently trading at $241.48, which is 20.1% above its GF Value™ of $201.04, according to GuruFocus. The company has a GF Score™ of 84/100, indicating strong overall performance, with notable strengths in growth and profitability. Insider activity shows $2.4 million in buying over the last three months.

Welltower Inc. (WELL) is a healthcare REIT. The article cites WELL’s stock performance versus the S&P 500 and REZ, and attributes gains to senior housing NOI growth, occupancy recovery, pricing power, demographics, and capital recycling. It reports Q2 FFO of $1.60 vs $1.55 expected, revenue $3.5B, and full-year FFO guidance $3.11 to $3.19. Analysts rate it a “Strong Buy” with a KeyBanc $275 target.

Welltower reported Q2 2026 results and balance sheet progress. On an earnings call, the REIT cited acquisitions including Amica Senior Lifestyles (38 communities, $1.91B) and a July 2 Canada deal (five development properties, ~$459M). It also disposed of $7.2B outpatient medical properties. Q2 revenue rose to $3.54B, FFO to $1.60/share, and net income to $12.2B.

Premarket movers included Coca-Cola, Sherwin-Williams, Hilton, Johnson & Johnson, Corning, Cadence Design Systems, Rambus, Universal Health Services, Welltower, Happen (formerly LendingClub), and Cincinnati Financial. Key catalysts were earnings beats or misses and guidance changes, including J&J’s $5.5 billion talc settlement and Coca-Cola’s raised outlook after EPS and revenue topped estimates.